The multiple roles of EG-VEGF/PROK1 in normal and pathological placental angiogenesis

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Alfaidy, Nadia ^a,b,c   Hoffmann, Pascale ^a,b,c,d   Boufettal, Houssine ^e,f   Samouh, Naima ^e   Aboussaouira, Touria ^f   Benharouga, Mohamed ^a,b,g   Feige, Jean Jacques ^a,b,c   Brouillet, Sophie ^a,b,c,d  

^a DIF   (France)

^b UNIV GRENOBLE ALPES   (France)

^c CEA GRENOBLE   (France)

^d GRENOBLE UNIVERSITY HOSPITAL   (France)

^e IBN ROCHD UNIVERSITY HOSPITAL   (Morocco)

^f Centre d'Immunologie   (Morocco)

^g CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; ENDOCRINE GLAND DERIVED VASCULAR ENDOTHELIAL GROWTH FACTOR; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; VASCULOTROPIN; GASTROINTESTINAL HORMONE; PROK1 PROTEIN, HUMAN;

ANGIOGENESIS; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; ENDOTHELIUM CELL; HUMAN; HYPOXIA; INTRAUTERINE GROWTH RETARDATION; PLACENTA; PLACENTA DEVELOPMENT; PREECLAMPSIA; PREGNANCY; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; TROPHOBLASTIC DISEASE; UPREGULATION; VASCULARIZATION; FEMALE; GENETICS; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY;

FEMALE; GASTROINTESTINAL HORMONES; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; PLACENTA; PREGNANCY; VASCULAR ENDOTHELIAL GROWTH FACTOR, ENDOCRINE-GLAND-DERIVED;

EID: 84901750291     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/451906     Document Type: Review

References (90)

1. Burton G. J., Jauniaux E., Sonographic, stereological and Doppler flow velocimetric assessments of placental maturity. British Journal of Obstetrics and Gynaecology 1995 102 10 818 825 2-s2.0-0028862778
2. Jackson M. R., Mayhew T. M., Boyd P. A., Quantitative description of the elaboration and maturation of villi from 10 weeks of gestation to term. Placenta 1992 13 4 357 370 2-s2.0-0026649502
3. Charnock-Jones D. S., Kaufmann P., Mayhew T. M., Aspects of human fetoplacental vasculogenesis and angiogenesis. I. Molecular regulation. Placenta 2004 25 2-3 103 113 2-s2.0-1342304434 10.1016/j.placenta.2003.10.004 (Pubitemid 38248055)
4. Kaufmann P., Mayhew T. M., Charnock-Jones D. S., Aspects of human fetoplacental vasculogenesis and angiogenesis. II. Changes during normal pregnancy. Placenta 2004 25 2-3 114 126 2-s2.0-1342283266 10.1016/j.placenta. 2003.10.009 (Pubitemid 38248056)
5. Benirschke K., Kaufmann P., Pathology of the Human Placenta 2000 4th New Tork, NY, USA Springer
6. Dellian M., Witwer B. P., Salehi H. A., Yuan F., Jain R. K., Quantitation and physiological characterization of angiogenic vessels in mice: effect of basic fibroblast growth factor, vascular endothelial growth factor/vascular permeability factor, and host microenvironment. American Journal of Pathology 1996 149 1 59 71 2-s2.0-0029900738 (Pubitemid 26230979)
7. Palade G. E., Simionescu M., Simionescu N., Structural aspects of the permeability of the microvascular endothelium. Acta Physiologica Scandinavica 1979 106 463 11 32 2-s2.0-0018336681 (Pubitemid 9210092)
8. Roberts W. G., Delaat J., Nagane M., Huang S., Cavenee W. K., Palade G. E., Host microvasculature influence on tumor vascular morphology and endothelial gene expression. The American Journal of Pathology 1998 153 4 1239 1248 2-s2.0-0031718447 (Pubitemid 28465847)
9. Stewart P. A., Wiley M. J., Developing nervous tissue induces formation of blood-brain barrier characteristics in invading endothelial cells: a study using quail-chick transplantation chimeras. Developmental Biology 1981 84 1 183 192 2-s2.0-0019798883 (Pubitemid 11092411)
10. Lecouter J., Kowalski J., Foster J., Hass P., Zhang Z., Dillard-Telm L., Frantz G., Rangell L., Deguzman L., Keller G. A., Peale F., Gurney A., Hillan K. J., Ferrara N., Identification of an angiogenic mitogen selective for endocrine gland endothelium. Nature 2001 412 6850 877 884 2-s2.0-0035974803 10.1038/35091000 (Pubitemid 32821726)
11. Lin D. C., Bullock C. M., Ehlert F. J., Chen J. L., Tian H., Zhou Q. Y., Identification and molecular characterization of two closely related G protein-coupled receptors activated by prokineticins/endocrine gland vascular endothelial growth factor. Journal of Biological Chemistry 2002 277 22 19276 19280 2-s2.0-0037205491 10.1074/jbc.M202139200 (Pubitemid 34967431)
12. Urayama K., Dedeoglu D. B., Guilini C., Frantz S., Ertl G., Messaddeq N., Nebigil C. G., Transgenic myocardial overexpression of prokineticin receptor-2 (GPR73b) induces hypertrophy and capillary vessel leakage. Cardiovascular Research 2009 81 1 28 37 2-s2.0-57749194568 10.1093/cvr/cvn251
13. Urayama K., Guilini C., Messaddeq N., Hu K., Steenman M., Kurose H., Ert G., Nebigil C. G., The prokineticin receptor-1 (GPR73) promotes cardiomyocyte survival and angiogenesis. The FASEB Journal 2007 21 11 2980 2993 2-s2.0-34548501528 10.1096/fj.07-8116com (Pubitemid 47372764)
14. Guilini C., Urayama K., Turkeri G., Dedeoglu D. B., Kurose H., Messaddeq N., Nebigil C. G., Divergent roles of prokineticin receptors in the endothelial cells: angiogenesis and fenestration. The American Journal of Physiology-Heart and Circulatory Physiology 2010 298 3 H844 H852 2-s2.0-77749264430 10.1152/ajpheart.00898.2009
15. Kisliouk T., Levy N., Hurwitz A., Meidan R., Presence and regulation of endocrine gland vascular endothelial growth factor/prokineticin-1 and its receptors in ovarian cells. Journal of Clinical Endocrinology and Metabolism 2003 88 8 3700 3707 2-s2.0-0042885557 10.1210/jc.2003-030492 (Pubitemid 37034517)
16. Kisliouk T., Podlovni H., Meidan R., Unique expression and regulatory mechanisms of EG-VEGF/prokineticin-1 and its receptors in the corpus luteum. Annals of Anatomy 2005 187 5-6 529 537 2-s2.0-28344452037 10.1016/j.aanat.2005. 07.005 (Pubitemid 41715511)
17. Catalano R. D., Lannagan T. R. M., Gorowiec M., Denison F. C., Norman J. E., Jabbour H. N., Prokineticins: novel mediators of inflammatory and contractile pathways at parturition? Molecular Human Reproduction 2010 16 5 311 319 2-s2.0-77954072909 10.1093/molehr/gaq014
18. Kisliouk T., Podlovni H., Spanel-Borowski K., Ovadia O., Zhou Q. Y., Meidan R., Prokineticins (endocrine gland-VEGF and BV8) in the bovine ovary: expression and role as mitogens and survival factors for corpus luteum derived-endothelial cells. Endocrinology 2005 146 9 3950 3958 2-s2.0-23844458338 10.1210/en.2005-0297 (Pubitemid 41175766)
19. LeCouter J., Ferrara N., EG-VEGF and the concept of tissue-specific angiogenic growth factors. Seminars in Cell and Developmental Biology 2002 13 1 3 8 2-s2.0-0036445595 10.1006/scdb.2001.0284 (Pubitemid 35418309)
20. Lin R., LeCouter J., Kowalski J., Ferrara N., Characterization of endocrine gland-derived vascular endothelial growth factor signaling in adrenal cortex capillary endothelial cells. Journal of Biological Chemistry 2002 277 10 8724 8729 2-s2.0-0037041028 10.1074/jbc.M110594200 (Pubitemid 34968340)
21. Brouillet S., Hoffmann P., Benharouga M., Salomon A., Schaal J. P., Feige J. J., Alfaidy N., Molecular characterization of EG-VEGF-mediated angiogenesis: differential effects on microvascular and macrovascular endothelial cells. Molecular Biology of the Cell 2010 21 16 2832 2843 2-s2.0-77955631554 10.1091/mbc.E10-01-0059
22. Hoffmann P., Feige J.-J., Alfaidy N., Expression and oxygen regulation of endocrine gland-derived vascular endothelial growth factor/prokineticin-1 and its receptors in human placenta during early pregnancy. Endocrinology 2006 147 4 1675 1684 2-s2.0-33645499859 10.1210/en.2005-0912
23. Hoffmann P., Saoudi Y., Benharouga M., Graham C. H., Schaal J. P., Mazouni C., Feige J. J., Alfaidy N., Role of EG-VEGF in human placentation: physiological and pathological implications. Journal of Cellular and Molecular Medicine 2009 13 8 B 2224 2235 2-s2.0-72949101232 10.1111/j.1582-4934.2008. 00554.x
24. Denison F. C., Battersby S., King A. E., Szuber M., Jabbour H. N., Prokineticin-1: a novel mediator of the inflammatory response in third-trimester human placenta. Endocrinology 2008 149 7 3470 3477 2-s2.0-46349090413 10.1210/en.2007-1695 (Pubitemid 351919616)
25. Matjila M., Millar R., van der Spuy Z., Katz A., The differential expression of Kiss1, MMP9 and angiogenic regulators across the feto-maternal interface of healthy human pregnancies: implications for trophoblast invasion and vessel development. PLoS ONE 2013 8 5 e63574
26. Evans J., Catalano R. D., Morgan K., Critchley H. O. D., Millar R. P., Jabbour H. N., Prokineticin 1 signaling and gene regulation in early human pregnancy. Endocrinology 2008 149 6 2877 2887 2-s2.0-44249094625 10.1210/en.2007-1633 (Pubitemid 351724502)
27. Brouillet S., Murthi P., Hoffmann P., EG-VEGF controls placental growth and survival in normal and pathological pregnancies: case of fetal growth restriction (FGR). Cellular and Molecular Life Sciences 2013 70 3 511 525 10.1007/s00018-012-1141-z
28. Jauniaux E., Hempstock J., Greenwold N., Burton G. J., Trophoblastic oxidative stress in relation to temporal and regional differences in maternal placental blood flow in normal and abnormal early pregnancies. The American Journal of Pathology 2003 162 1 115 125 2-s2.0-0037219342 (Pubitemid 36041994)
29. Burton G. J., Jauniaux E., Placental oxidative stress: from miscarriage to preeclampsia. Journal of the Society for Gynecologic Investigation 2004 11 6 342 352 2-s2.0-4444347073 10.1016/j.jsgi.2004.03.003 (Pubitemid 39185874)
30. Zetter B. R., The endothelial cells of large and small blood vessels. Diabetes 1981 30 2 24 28 2-s2.0-0019738662
31. Fajardo L. F., Special report. The complexity of endothelial cells. A review. The American Journal of Clinical Pathology 1989 92 2 241 250 2-s2.0-0024708668 (Pubitemid 19187707)
32. Bicknell R., Heterogeneity of the endothelial cell. Behring Institute Mitteilungen 1993 92 1 7 2-s2.0-0027640468
33. Lang I., Hoffmann C., Olip H., Pabst M. A., Hahn T., Dohr G., Desoye G., Differential mitogenic responses of human macrovascular and microvascular endothelial cells to cytokines underline their phenotypic heterogeneity. Cell Proliferation 2001 34 3 143 155 2-s2.0-0035009980 10.1046/j.1365-2184.2001. 00205.x (Pubitemid 32523216)
34. Lang I., Pabst M. A., Hiden U., Blaschitz A., Dohr G., Hahn T., Desoye G., Heterogeneity of microvascular endothelial cells isolated from human term placenta and macrovascular umbilical vein endothelial cells. European Journal of Cell Biology 2003 82 4 163 173 2-s2.0-0038069208 10.1078/0171-9335-00306 (Pubitemid 36546617)
35. Lang I., Hartmann M., Blaschitz A., Dohr G., Skofitsch G., Desoye G., Immunohistochemical evidence for the heterogeneity of maternal and fetal vascular endothelial cells in human full-term placenta. Cell and Tissue Research 1993 274 2 211 218 2-s2.0-0027497244 10.1007/BF00318740 (Pubitemid 23307474)
36. Challier J. C., Kacemi A., Olive G., Mixed culture of pericytes and endothelial cells from fetal microvessels of the human placenta. Cellular and Molecular Biology 1995 41 2 233 241 2-s2.0-0029265091
37. Kacemi A., Galtier M., Espié M. J., Challier J. C., Isolation of villous microvessels from the human placenta. Comptes Rendus de l'Académie des Sciences III 1997 320 2 171 177 10.1016/S0764-4469(97) 85009-3 (Pubitemid 27170985)
38. Ugele B., Lange F., Isolation of endothelial cells from human placental microvessels: effect of different proteolytic enzymes on releasing endothelial cells from villous tissue. In Vitro Cellular & Developmental Biology 2001 37 7 408 413 (Pubitemid 32880536)
39. Wang X., Athayde N., Trudinger B., A proinflammatory cytokine response is present in the fetal placental vasculature in placental insufficiency. The American Journal of Obstetrics and Gynecology 2003 189 5 1445 1451 2-s2.0-0347381372 10.1067/S0002-9378(03)00652-5 (Pubitemid 37542188)
40. Dye J. F., Vause S., Johnston T., Clark P., Firth J. A., D'Souza S. W., Sibley C. P., Glazier J. D., Characterization of cationic amino acid transporters and expression of endothelial nitric oxide synthase in human placental microvascular endothelial cells. The FASEB Journal 2004 18 1 125 127 2-s2.0-1342310792
41. Murthi P., So M., Gude N. M., Doherty V. L., Brennecke S. P., Kalionis B., Homeobox genes are differentially expressed in macrovascular human umbilical vein endothelial cells and microvascular placental endothelial cells. Placenta 2007 28 2-3 219 223 2-s2.0-33845487308 10.1016/j.placenta.2006.02.012 (Pubitemid 44914527)
42. Murray J. D., On the mechanochemical theory of biological pattern formation with application to vasculogenesis. Comptes Rendus-Biologies 2003 326 2 239 252 2-s2.0-0038748330 10.1016/S1631-0691(03)00065-9 (Pubitemid 36546346)
43. Davis G. E., Senger D. R., Endothelial extracellular matrix: biosynthesis, remodeling, and functions during vascular morphogenesis and neovessel stabilization. Circulation Research 2005 97 11 1093 1107 2-s2.0-33644683263 10.1161/01.RES.0000191547.64391.e3
44. Donovan D., Brown N. J., Bishop E. T., Lewis C. E., Comparison of three in vitro human "angiogenesis" assays with capillaries formed in vivo. Angiogenesis 2001 4 2 113 121 2-s2.0-0035671571 10.1023/A:1012218401036 (Pubitemid 34032697)
45. Rodriguez L. G., Wu X., Guan J. L., Wound-healing assay. Methods in Molecular Biology 2005 294 23 29 2-s2.0-21644435059
46. Miller R. K., Genbacev O., Turner M. A., Aplin J. D., Caniggia I., Huppertz B., Human placental explants in culture: approaches and assessments. Placenta 2005 26 6 439 448 2-s2.0-20444368804 10.1016/j.placenta.2004.10.002 (Pubitemid 40796572)
47. Genbacev O., Zhou Y., Ludlow J. W., Fisher S. J., Regulation of human placental development by oxygen tension. Science 1997 277 5332 1669 1672 2-s2.0-0030879909 10.1126/science.277.5332.1669 (Pubitemid 27446230)
48. Burton G. J., Jauniaux E., Watson A. L., Maternal arterial connections to the placental intervillous space during the first trimester of human pregnancy: the Boyd Collection revisited. The American Journal of Obstetrics and Gynecology 1999 181 3 718 724 2-s2.0-0032876371 10.1016/S0002-9378(99)70518-1 (Pubitemid 29453538)
49. Zygmunt M., Herr F., Keller-Schoenwetter S., Kunzi-Rapp K., Münstedt K., Rao C. V., Lang U., Preissner K. T., Characterization of human chorionic gonadotropin as a novel angiogenic factor. Journal of Clinical Endocrinology and Metabolism 2002 87 11 5290 5296 2-s2.0-0036847113 10.1210/jc.2002-020642 (Pubitemid 35316376)
50. Islami D., Bischof P., Chardonnens D., Modulation of placental vascular endothelial growth factor by leptin and hCG. Molecular Human Reproduction 2003 9 7-8 395 398 2-s2.0-0038148736 (Pubitemid 36874297)
51. Brouillet S., Hoffmann P., Chauvet S., Salomon A., Chamboredon S., Sergent F., Benharouga M., Feige J. J., Alfaidy N., Revisiting the role of hCG: new regulation of the angiogenic factor EG-VEGF and its receptors. Cellular and Molecular Life Sciences 2012 69 9 1537 1550 2-s2.0-82355163991
52. Herr F., Baal N., Reisinger K., Lorenz A., McKinnon T., Preissner K. T., Zygmunt M., HCG in the regulation of placental angiogenesis. Results of an in vitro study. Placenta 2007 28 supplement 1 S85 S93 2-s2.0-33947728558 10.1016/j.placenta.2007.02.002 (Pubitemid 46506062)
53. Sa G., Murugesan G., Jaye M., Ivashchenko Y., Fox P. L., Activation of cytosolic phospholipase A2 by basic fibroblast growth factor via a p42 mitogen-activated protein kinase-dependent phosphorylation pathway in endothelial cells. Journal of Biological Chemistry 1995 270 5 2360 2366 2-s2.0-0028930542 10.1074/jbc.270.5.2360
54. Matsumoto T., Turesson I., Book M., Gerwins P., Claesson-Welsh L., p38 MAP kinase negatively regulates endothelial cell survival, proliferation, and differentiation in FGF-2-stimulated angiogenesis. Journal of Cell Biology 2002 156 1 149 160 2-s2.0-0037033794 10.1083/jcb.200103096 (Pubitemid 34846943)
55. Kuida K., Boucher D. M., Functions of MAP kinases: Insights from gene-targeting studies. Journal of Biochemistry 2004 135 6 653 656 2-s2.0-3142517825 10.1093/jb/mvh078 (Pubitemid 38899711)
56. Karar J., Maity A., PI3K/AKT/mTOR Pathway in Angiogenesis. Frontiers in Molecular Neuroscience 2011 4, article 51 10.3389/fnmol.2011.00051
57. Wang K., Zheng J., Signaling regulation of fetoplacental angiogenesis. Journal of Endocrinology 2012 212 3 243 255 2-s2.0-84857850521 10.1530/JOE-11-0296
58. Kayisli U. A., Demir R., Erguler G., Arici A., Vasodilator-stimulated phosphoprotein expression and its cytokine-mediated regulation in vasculogenesis during human placental development. Molecular Human Reproduction 2002 8 11 1023 1030 2-s2.0-0036848351 (Pubitemid 35331807)
59. Saito S., Kasahara T., Sakakura S., Umekage H., Harada N., Ichijo M., Detection and localization of interleukin-8 mRNA and protein in human placenta and decidual tissues. Journal of Reproductive Immunology 1994 27 3 161 172 2-s2.0-0028588057 10.1016/0165-0378(94)90001-9
60. Colditz I. G., Effect of exogenous prostaglandin E2 and actinomycin D on plasma leakage induced by neutrophil-activating peptide-1/interleukin-8. Immunology and Cell Biology 1990 68 6 397 403 2-s2.0-0025615486
61. Kim K. S., Rajagopal V., Gonsalves C., Johnson C., Kalra V. K., A novel role of hypoxia-inducible factor in cobalt chloride- and hypoxia-mediated expression of IL-8 chemokine in human endothelial cells. Journal of Immunology 2006 177 10 7211 7224 2-s2.0-33750802140 (Pubitemid 44715090)
62. Bowen R. S., Gu Y., Zhang Y., Lewis D. F., Wang Y., Hypoxia promotes interleukin-6 and -8 but reduces interleukin-10 production by placental trophoblast cells from preeclamptic pregnancies. Journal of the Society for Gynecologic Investigation 2005 12 6 428 432 2-s2.0-24144475295 10.1016/j.jsgi.2005.04.001 (Pubitemid 41242382)
63. Cross M. J., Dixelius J., Matsumoto T., Claesson-Welsh L., VEGF-receptor signal transduction. Trends in Biochemical Sciences 2003 28 9 488 494 2-s2.0-0642306485 10.1016/S0968-0004(03)00193-2 (Pubitemid 38340413)
64. Brouillet S., Hoffmann P., Feige J. J., Alfaidy N., EG-VEGF: a key endocrine factor in placental development. Trends in Endocrinology and Metabolism 2012 23 10 501 508 10.1016/j.tem.2012.05.006
65. Brouillet S., Hoffmann P., Thomas-Cadi C., PROK1, prognostic marker of embryo implantation? Gynécologie Obstétrique & Fertilité 2013 41 9 562 565 10.1016/j.gyobfe.2013.07.007
66. Su M. T., L. S. H., Chen Y. C., Wu L. W., Kuo P. L., Prokineticin receptor variants (PKR1-I379V and PKR2-V331M) are protective genotypes in human early pregnancy. Reproduction 2013 146 1 63 73 10.1530/REP-13-0043
67. Su M. T., Lin S. H., Lee I. W., Chen Y. C., Hsu C. C., Pan H. A., Kuo P. L., Polymorphisms of endocrine gland-derived vascular endothelial growth factor gene and its receptor genes are associated with recurrent pregnancy loss. Human Reproduction 2010 25 11 2923 2930 2-s2.0-77958129854 10.1093/humrep/deq256
68. Salker M., Teklenburg G., Molokhia M., Lavery S., Trew G., Aojanepong T., Mardon H. J., Lokugamage A. U., Rai R., Landles C., Roelen B. A. J., Quenby S., Kuijk E. W., Kavelaars A., Heijnen C. J., Regan L., Macklon N. S., Brosens J. J., Natural selection of human embryos: impaired decidualization of endometrium disables embryo-maternal interactions and causes recurrent pregnancy loss. PLoS ONE 2010 5 4 2-s2.0-77954295316 10.1371/journal.pone.0010287 e10287
69. Vuorela P., Carpén O., Tulppala M., Halmesmäki E., VEGF, its receptors and the Tie receptors in recurrent miscarriage. Molecular Human Reproduction 2000 6 3 276 282 2-s2.0-0034005203 (Pubitemid 30120623)
70. Zygmunt M., Herr F., Münstedt K., Lang U., Liang O. D., Angiogenesis and vasculogenesis in pregnancy. European Journal of Obstetrics & Gynecology and Reproductive Biology 2003 110 supplement 1 S10 S18 10.1016/S0301-2115(03)00168-4 (Pubitemid 37074857)
71. Manolea M. M., Gavrilǎ O. A., Popescu F. C., Novac L., Mateescu G. O., The importance of immunohistochemical evaluation of the vascular changes from the decidua and placenta in recurrent pregnancy loss. Romanian Journal of Morphology and Embryology 2012 53 2 363 368
72. Boufettal H., Feige J. J., Benharouga M., Potential role of the angiogenic factor, "EG-VEGF" in gestational trophoblastic diseases. Pathologie Biologie 2013 61 5 178 183 10.1016/j.patbio.2013.02.001
73. Bolat F., Haberal N., Tunali N., Aslan E., Bal N., Tuncer I., Expression of vascular endothelial growth factor (VEGF), hypoxia inducible factor 1 alpha (HIF-1 α), and transforming growth factors β 1 (TGF β 1) and β 3 (TGF β 3) in gestational trophoblastic disease. Pathology Research and Practice 2010 206 1 19 23 2-s2.0-73649093738 10.1016/j.prp.2009.07.017
74. Tuncer Z. S., Vegh G. L., Fulop V., Genest D. R., Mok S. C., Berkowitz R. S., Expression of epidermal growth factor receptor-related family products in gestational trophoblastic diseases and normal placenta and its relationship with development of postmolar tumor. Gynecologic Oncology 2000 77 3 389 393 2-s2.0-0034129937 10.1006/gyno.2000.5777 (Pubitemid 30368555)
75. Szuber M., Markwitz W., Ropacka M., Breborowicz G. H., The possible role of the PK1 and its receptor in the etiology of the preeclampsia. Neuroendocrinology Letters 2011 32 4 563 572 2-s2.0-80053549412
76. WHO, World Health Report: Make Every Mother and Child Count 2005 Geneva, Switzerland World Health Organization
77. Sibai B., Dekker G., Kupferminc M., Pre-eclampsia. The Lancet 2005 365 9461 785 799 2-s2.0-14644412849 10.1016/S0140-6736(05)17987-2 (Pubitemid 40311367)
78. Meekins J. W., Pijnenborg R., Hanssens M., McFadyen I. R., Van Asshe A., A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies. British Journal of Obstetrics and Gynaecology 1994 101 8 669 674 2-s2.0-0027964281 (Pubitemid 24251519)
79. Levine R. J., Maynard S. E., Qian C., Circulating angiogenic factors and the risk of preeclampsia. The New England Journal of Medicine 2004 350 7 672 683 10.1056/NEJMoa031884 (Pubitemid 38364626)
80. Cole L. A., New discoveries on the biology and detection of human chorionic gonadotropin. Reproductive Biology and Endocrinology 2009 7, article 8 2-s2.0-62149105580 10.1186/1477-7827-7-8
81. Liu D. F., Dickerman L. H., Redline R. W., Pathologic findings in pregnancies with unexplained increases in midtrimester maternal serum human chorionic gonadotropin levels. The American Journal of Clinical Pathology 1999 111 2 209 215 2-s2.0-0344889203 (Pubitemid 29054948)
82. Douglas Wilson R., Gagnon A., Obstetrical complications associated with abnormal maternal serum markers analytes. Journal of Obstetrics & Gynaecology 2008 30 10 918 949
83. Cole L. A., hCG and hyperglycosylated hCG in the establishment and evolution of hemochorial placentation. Journal of reproductive immunology 2009 82 2 112 118 2-s2.0-77953421744
84. Kingdom J., Huppertz B., Seaward G., Kaufmann P., Development of the placental villous tree and its consequences for fetal growth. European Journal of Obstetrics Gynecology and Reproductive Biology 2000 92 1 35 43 2-s2.0-0033795787 10.1016/S0301-2115(00)00423-1
85. Cetin I., Foidart J. M., Miozzo M., Raun T., Jansson T., Tsatsaris V., Reik W., Cross J., Hauguel-de-Mouzon S., Illsley N., Kingdom J., Huppertz B., Fetal growth restriction: a workshop report. Placenta 2004 25 8-9 753 757 2-s2.0-4444282160 10.1016/j.placenta.2004.02.004 (Pubitemid 39185955)
86. Khong T. Y., De Wolf F., Robertson W. B., Brosens I., Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. British Journal of Obstetrics and Gynaecology 1986 93 10 1049 1059 2-s2.0-0022514874 (Pubitemid 16004866)
87. Zhou Y., Damsky C. H., Fisher S. J., Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype: one cause of defective endovascular invasion in this syndrome? Journal of Clinical Investigation 1997 99 9 2152 2164 2-s2.0-0030979721 (Pubitemid 27203771)
88. Fitzgerald B., Levytska K., Kingdom J., Walker M., Baczyk D., Keating S., Villous trophoblast abnormalities in extremely preterm deliveries with elevated second trimester maternal serum hCG or inhibin-A. Placenta 2011 32 4 339 345 2-s2.0-79952737487 10.1016/j.placenta.2011.01.018
89. Krantz D., Goetzl L., Simpson J. L., Thom E., Zachary J., Hallahan T. W., Silver R., Pergament E., Platt L. D., Filkins K., Johnson A., Mahoney M., Hogge W. A., Wilson R. D., Mohide P., Hershey D., Wapner R., Association of extreme first-trimester free human chorionic gonadotropin- β pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes. The American Journal of Obstetrics and Gynecology 2004 191 4 1452 1458 2-s2.0-7044261025 10.1016/j.ajog.2004.05.068 (Pubitemid 39421613)
90. Todros T., Sciarrone A., Piccoli E., Guiot C., Kaufmann P., Kingdom J., Umbilical doppler waveforms and placental villous angiogenesis in pregnancies complicated by fetal growth restriction. Obstetrics and Gynecology 1999 93 4 499 503 2-s2.0-0033012518 (Pubitemid 29147065)